Who owns NEWAMSTERDAM PHARMA CO NV?
- Ticker: NAMSW
- CUSIP Number: n62509117
Tip: Access positions for across all investors
Analyze quarterly positions in Newamsterdam Pharma Co Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Newamsterdam Pharma Co Nv stock
Who bought or sold NEWAMSTERDAM PHARMA CO NV this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Frazier Life Sciences Management | 500k | $3.5M | 0% | Sep 2024 |
|
| RA Capital Management | 333k | $2.3M | 0% | Sep 2024 |
|
| Affinity Asset Advisors | 213k | $1.5M | 5% | Sep 2024 |
|
| Bain Capital Life Sciences Investors | 100k | $700k | 0% | Sep 2024 |
|
| Deerfield Management Company | 93k | $650k | 0% | Sep 2024 |
|
| Millennium Management | 75k | $525k | 0% | Sep 2024 |
|
| Monashee Investment Management | 31k | $218k | 100% | Sep 2024 |
|
| Hrt Financial | 27k | $189k | -11% | Sep 2024 |
|
| Laurion Capital Management | 17k | $117k | 0% | Sep 2024 |
|
| Vestcor Investment Management Corp | 9.6k | $67k | 100% | Sep 2024 |
|
| TFC Financial Management | 6.2k | $43k | -38% | Sep 2024 |
|
| Atlantic Trust | 1.0k | $7.1k | 0% | Sep 2024 |
|